|
SRPK1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.432200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.539000E-01 |
| Normal-vs-Stage2 |
8.825800E-01 |
| Normal-vs-Stage3 |
7.943000E-01 |
| Normal-vs-Stage4 |
9.291000E-01 |
| Stage1-vs-Stage2 |
3.997600E-01 |
| Stage1-vs-Stage3 |
2.913200E-01 |
| Stage1-vs-Stage4 |
5.509800E-01 |
| Stage2-vs-Stage3 |
9.635400E-01 |
| Stage2-vs-Stage4 |
9.603400E-01 |
| Stage3-vs-Stage4 |
9.217400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.592200E-01 |
| Normal-vs-AfricanAmerican |
5.887200E-01 |
| Normal-vs-Asian |
5.419800E-01 |
| Caucasian-vs-AfricanAmerican |
9.929400E-01 |
| Caucasian-vs-Asian |
6.614200E-01 |
| AfricanAmerican-vs-Asian |
6.211400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.689800E-02 |
| Normal-vs-Female |
4.367800E-02 |
| Male-vs-Female |
1.317790E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.941000E-01 |
| Normal-vs-Extreme_Weight |
7.363800E-04 |
| Normal-vs-Obese |
2.826600E-01 |
| Normal-vs-Extreme_Obese |
8.572000E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.301900E-02 |
| Normal_Weight-vs-Obese |
1.339400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.055200E-01 |
| Extreme_Weight-vs-Obese |
4.641600E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.189400E-01 |
| Obese-vs-Extreme_Obese |
3.276100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.601800E-02 |
| Normal-vs-Age(41-60Yrs) |
8.820600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.476560E-01 |
| Normal-vs-Age(81-100Yrs) |
8.48549999999948E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.143900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.358200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.540800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.063400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.340860E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.276360E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.222400E-01 |
| Normal-VS-Type2 PRCC |
1.310970E-01 |
| Normal-VS-KIRP CIMP |
5.520300E-02 |
| Normal-VS-Unclassified PRCC |
5.507200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.060800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.425700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.964000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.579700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.832200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.697900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.336370E-02 |
| Normal-vs-N1 |
6.380100E-02 |
| Normal-vs-N2 |
5.558200E-01 |
| N0-vs-N1 |
9.597500E-03 |
| N0-vs-N2 |
8.552800E-01 |
| N1-vs-N2 |
2.919200E-01 |
|
|
